International alert as fake Ozempic leads to serious hospitalizations
With an industry expected to be worth US$100 billion by 2030, an ongoing supply crisis, a time-consuming manufacturing process, a high price tag and no generic alternatives, it's no surprise the much-hyped class of injectable weight-loss drugs has become a prime target for counterfeit trade.
Tags: FDA, Drugs, Weight Loss, Counterfeiting
Comentarios
Publicar un comentario